ArticleScientific reports2023

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma.

Lenka Besse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.